CARE Ratings Reaffirms Credit Rating for KEI Industries Limited on Bank Facilities and Commercial Paper
CARE Ratings Limited has reaffirmed the credit ratings for KEI Industries Limited concerning its banking facilities and commercial paper, noting the company's operational and financial performance. The ratings highlight the strong safety profile associated with KEI’s instruments.According to CARE Ratings, the Long Term Bank Facilities of KEI Industries Limited have been rated CARE AA+ with a Stable outlook. This rating signifies that these instruments carry very low credit risk and are considered to have a high degree of safety regarding the timely servicing of financial obligations.
For its Short Term Bank Facilities/Commercial Paper, the company has received a rating of CARE A1+, which is defined as having the lowest credit risk and demonstrating a very strong degree of safety for the timely payment of financial obligations.
CARE Ratings also reviewed the credit profile specifically for a Commercial Paper (CP) issue aggregating ₹30.00 crore. The CP was reaffirmed with a rating of CARE A1+. This commercial paper is intended for a maturity not exceeding one year.
The ratings details are as follows:
| Instrument Type | Rating / Outlook | Credit Risk Assessment |
|---|---|---|
| Long Term Bank Facilities | CARE AA+; Stable | Instruments carry very low credit risk and show high degree of safety regarding timely servicing of financial obligations. |
| Short Term Bank Facilities/ Commercial Paper | CARE A1+ (A One Plus) | These instruments carry the lowest credit risk and are considered to have a very strong degree of safety regarding timely payment of financial obligations. |
Stock Price Movement
Colinz Laboratories Ltd settled late Thursday at ₹75.55, registering a 4.99% gain for the day. This performance was locked as the shares traded completely flat throughout the session, maintaining that exact price point.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.